stella
beta
A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC — Stella
Recruiting
Back to Non Small Cell Lung Cancer trials
Trial locations
(1 site)
China
Beijing Cancer Prevention society, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov